American Association for Cancer Research
Browse
00085472can150562-sup-146000_2_supp_3017941_npttzy_eps_zip.zip (322.52 kB)

Supplementary Table S6 from Metastatic Competence Can Emerge with Selection of Preexisting Oncogenic Alleles without a Need of New Mutations

Download (322.52 kB)
software
posted on 2023-03-30, 23:02 authored by Leni S. Jacob, Sakari Vanharanta, Anna C. Obenauf, Mono Pirun, Agnes Viale, Nicholas D. Socci, Joan Massagué

Supplementary Table S6. Primers used in this study are listed.

History

ARTICLE ABSTRACT

Several experimental models faithfully recapitulate many important facets of human metastatic disease. Here, we have performed whole-exome sequencing in five widely used experimental metastasis models that were independently derived through in vivo selection from heterogeneous human cancer cell lines. In addition to providing an important characterization of these model systems, our study examines the genetic evolution of metastatic phenotypes. We found that in vivo selected highly metastatic cell populations showed little genetic divergence from the corresponding parental population. However, selection of genetic variations that preexisted in parental populations, including the well-established oncogenic mutations KRASG13D and BRAFG464V, was associated with increased metastatic capability. Conversely, expression of the wild-type BRAF allele in metastatic cells inhibited metastatic outgrowth as well as tumor initiation in mice. Our findings establish that metastatic competence can arise from heterogeneous cancer cell populations without the need for acquisition of additional mutations and that such competence can benefit from further selection of tumor-initiating mutations that seed primary tumorigenesis. Cancer Res; 75(18); 3713–9. ©2015 AACR.

Usage metrics

    Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC